ACC 2014 Report: Gastric surgery halves risk of heart attack in obese people
Obese people who have stomach surgery to help them lose weight will halve their risk of heart attack according to new research from a team of doctors at… read more.
Obese people who have stomach surgery to help them lose weight will halve their risk of heart attack according to new research from a team of doctors at… read more.
A comparison of the safety of biodegradable polymer biolimus-eluting stents vs durable polymer everolimus-eluting stents finds similar outcomes for measures including death and heart attack after two years,… read more.
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.
Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington. Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.
Poster Presentation: Study of alemtuzumab induction with tacrolimus maintenance monotherapy compared to IL2R blockade with tacrolimus/MMF maintenance in kidney transplantation by Adam McLean, Imperial College Kidney & Transplant… read more.
Quality assessment of human kidneys using ex-vivo normothermic perfusion by Adam Barlow, University Hospitals of Leicester – Ex-vivo normothermic perfusion is a viable method of preserving kidneys for… read more.
by Maria Dalby – Genetic polymorphisms are known to influence the pharmacokinetics of tacrolimus and may thus have a significant impact on the clinical outcome.
Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.
Maria Dalby reporting on the Oral Presentation by Marc Clancy, Western Infirmary, Glasgow – Although the mainstay of clinical immunosuppression since the 1980s, calcineurin inhibitors (CNIs) are narrow… read more.
Maria Dalby reporting on the Oral Presentation by Teun van Gelder, Erasmus Medical Centre Rotterdam, the Netherlands – Increasing use of generic drugs, escalating research and development costs… read more.
Maria Dalby reporting on the Oral Presentation by Peter Friend, Oxford Transplant Centre, University of Oxford et al. Peter Friend, Oxford Transplant Centre, University of Oxford / Chris… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.